Evidence map›Paper›PMID 39741824›Full record

ArticleACS omega2024

Release of Crystalline Silica Nanoparticles during Engineered Stone Fabrication.

Kabir Rishi, Bon Ki Ku, Chaolong Qi, Drew Thompson, Chen Wang, Alan Dozier, Vasileia Vogiazi, Orthodoxia Zervaki, Pramod Kulkarni

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kabir RishiHealth Effects Laboratory Division (HELD), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC),1090 Tusculum Ave,Cincinnati, Ohio 45226, United States.ORCID https://orcid.org/0000-0002-3159-031X
Bon Ki KuHealth Effects Laboratory Division (HELD), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC),1090 Tusculum Ave,Cincinnati, Ohio 45226, United States.ORCID https://orcid.org/0000-0002-1233-0790
Chaolong QiDivision of Field Studies and Engineering (DFSE),National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC),1090 Tusculum Ave,Cincinnati, Ohio 45226, United States.
Drew ThompsonDivision of Field Studies and Engineering (DFSE),National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC),1090 Tusculum Ave,Cincinnati, Ohio 45226, United States.ORCID https://orcid.org/0000-0003-4011-3619
Chen WangHealth Effects Laboratory Division (HELD), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC),1090 Tusculum Ave,Cincinnati, Ohio 45226, United States.ORCID https://orcid.org/0000-0002-2343-339X
Alan DozierHealth Effects Laboratory Division (HELD), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC),1090 Tusculum Ave,Cincinnati, Ohio 45226, United States.
Vasileia VogiaziHealth Effects Laboratory Division (HELD), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC),1090 Tusculum Ave,Cincinnati, Ohio 45226, United States.
Orthodoxia ZervakiHealth Effects Laboratory Division (HELD), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC),1090 Tusculum Ave,Cincinnati, Ohio 45226, United States.ORCID https://orcid.org/0000-0002-3481-506X
Pramod KulkarniHealth Effects Laboratory Division (HELD), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC),1090 Tusculum Ave,Cincinnati, Ohio 45226, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhalation exposure to respirable crystalline silica (RCS) during the fabrication of engineered stone-based kitchen countertops has been on the rise in recent years and has become a significant occupational health problem in the United States and globally. Little is known about the presence of nanocrystalline silica (NCS), i.e., particles below 100 nm. We present a methodology to quantify the crystalline silica content in the sub-100 nm size fraction of the aerosol released during engineered stone fabrication using X-ray diffraction (XRD) and Fourier transform infrared (FTIR) spectroscopy. Aerosol was generated in a test chamber designed per EN 1093-3 and sampled using cascade impactors. XRD and FTIR analysis showed the presence of both α-quartz (15-60%) and cristobalite (10-50%) polymorphs in all size fractions. With increasing particle size, the cristobalite content increased. Seventy percent of the total aerosol mass in the sub-100 nm fraction was found to be crystalline silica, qualitatively confirmed by electron diffraction and electron energy loss spectroscopy. The presence of other minerals was detected in all size fractions; no polymeric resin binder was detected in the sub-100 nm fraction. Although the sub-100 nm fraction was about 1% of the aerosol mass, it accounted for 4-24% of the aerosol surface area based on the total lung deposition. If the surface area is a more relevant exposure metric, the assessment of the efficacy of current engineering control systems using mass as an exposure metric may not provide adequate protection.

Identifiers

PMID39741824
PMCPMC11683610

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.